Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Frederick H. F. Chan, Zack Z. S. Goh, Xiaoli Zhu, Lorainne Tudor Car, Stanton Newman, Behram A. Khan & Konstadina Griva. (2023) Subjective cognitive complaints in end-stage renal disease: a systematic review and meta-analysis. Health Psychology Review 17:4, pages 614-640.
Read now
Read now
José Ramón González-Juanatey, Álvaro González-Franco, Patricia de Sequera, Marta Valls, Antonio Ramirez de Arellano, Elisenda Pomares & Diana Nieves. (2022) A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain. Journal of Medical Economics 25:1, pages 640-649.
Read now
Read now
Winde Jorissen, Lieven Annemans, Nicolas Louis, Andreas Nilsson & Michael Willis. (2022) Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium. Acta Clinica Belgica 77:6, pages 945-954.
Read now
Read now
Emel Aygören-Pürsün, Anette Bygum, Kathleen Beusterien, Emily Hautamaki, Zlatko Sisic, Henrik B Boysen & Teresa Caballero. (2016) Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema. Patient Preference and Adherence 10, pages 1699-1707.
Read now
Read now
Ya-Fang Ho & I-Chuan Li. (2016) The influence of different dialysis modalities on the quality of life of patients with end-stage renal disease: A systematic literature review. Psychology & Health 31:12, pages 1435-1465.
Read now
Read now
Gorden Muduma, Jane Shaw, Warren M Hart, Abayomi Odeyemi & Isaac Odeyemi. (2014) Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales. Patient Preference and Adherence 8, pages 1537-1546.
Read now
Read now
Martin Pfohl, Peter K. Schädlich, Franz-Werner Dippel & Katharina C. Koltermann. (2012) Health economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany. Journal of Medical Economics 15:sup2, pages 14-27.
Read now
Read now
Utako Shimizu, Shota Saito, Yiwei Lings, Noriaki Iino, Junichirou James Kazama & Kohei Akazawa. (2012) Cost-effectiveness achieved through changing the composition of renal replacement therapy in Japan. Journal of Medical Economics 15:3, pages 444-453.
Read now
Read now
Vesile Senol, Murat Hayri Sipahioglu, Ahmet Ozturk, Mahmut Argün & Cengiz Utaş. (2010) Important determinants of quality of life in a peritoneal dialysis population in Turkey. Renal Failure 32:10, pages 1196-1201.
Read now
Read now
Phil McEwan, Chris D. Poole, Tony Tetlow, Paul Holmes & Craig J. Currie. (2007) Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK. Current Medical Research and Opinion 23:sup1, pages S21-S31.
Read now
Read now
Phil McEwan, Chris D. Poole, Tony Tetlow, Paul Holmes & Craig J. Currie. (2007) Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK. Current Medical Research and Opinion 23:sup1, pages S7-S19.
Read now
Read now
Phil McEwan, John R. Peters, Klas Bergenheim & Craig J. Currie. (2006) Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster). Current Medical Research and Opinion 22:1, pages 121-129.
Read now
Read now
Phil McEwan, Keshwar Baboolal, Simon Dixon, Pete Conway & Craig J. Currie. (2005) Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years. Current Medical Research and Opinion 21:11, pages 1793-1800.
Read now
Read now
Articles from other publishers (74)
Sara W. Quist, Alexander V. van Schoonhoven, Stephan J. L. Bakker, Michał Pochopień, Maarten J. Postma, Jeanni M. T. van Loon & Jeroen H. J. Paulissen. (2023) Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands. Cardiovascular Diabetology 22:1.
Crossref
Crossref
Man Zhang & Chunfeng Cai. (2023) The experiences of patients with peritoneal dialysis: A systematic review of qualitative evidence protocol. PLOS ONE 18:7, pages e0288724.
Crossref
Crossref
Ümmühan AKTÜRK, Behice ERCİ & Gül DURAL. (2023) Comparison of Quality of Life and Comfort Levels in Patients with Three Different Chronic DiseasesÜÇ FARKLI KRONIK HASTALIĞI OLAN HASTALARINDA YAŞAM KALITESI VE KONFOR DÜZEYLERININ KARŞILAŞTIRILMASI. Samsun Sağlık Bilimleri Dergisi 8:1, pages 113-128.
Crossref
Crossref
Thomas Ward, Ruth D. Lewis, Tray Brown, Garth Baxter & Antonio Ramirez de Arellano. (2023) A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure. BMC Nephrology 24:1.
Crossref
Crossref
Mai Alsaqa’aby, Dema Alissa, Mohammed Hussein, Hajar Y. Almudaiheem & Ahmed Al-jedai. (2023) Cost-Utility of Immunosuppressive Therapy Post-Renal Transplantation in Saudi Arabia: The Saudi Ministry of Health Perspective. Value in Health Regional Issues 33, pages 56-64.
Crossref
Crossref
Phil McEwan, Oliver Darlington, Ryan Miller, John J.V. McMurray, David C. Wheeler, Hiddo J.L. Heerspink, Andrew Briggs, Klas Bergenheim & Juan Jose Garcia Sanchez. (2022) Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology 17:12, pages 1730-1741.
Crossref
Crossref
Gregory Mader, Deirdre Mladsi, Myrlene Sanon, Molly Purser, Christine L. Barnett, Dorothee Oberdhan, Terry Watnick & Stephen Seliger. (2022) A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease. BMC Nephrology 23:1.
Crossref
Crossref
Thomas Ward, Tray Brown, Ruth D. Lewis, Melodi Kosaner Kliess, Antonio Ramirez de Arellano & Carol M. Quinn. (2022) The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland. PharmacoEconomics - Open 6:5, pages 757-771.
Crossref
Crossref
Jonas Ehrsam, Fabian Rössler, Karoline Horisberger, Kerstin Hübel, Jakob Nilsson & Olivier de Rougemont. (2022) Kidney Retransplantation after Graft Failure: Variables Influencing Long-Term Survival. Journal of Transplantation 2022, pages 1-8.
Crossref
Crossref
Tadesse M. Abegaz, Vakaramoko Diaby, Fatimah Sherbeny & Askal Ayalew Ali. (2022) Cost Effectiveness of Dapagliflozin Added to Standard of Care for the Management of Diabetic Nephropathy in the USA. Clinical Drug Investigation 42:6, pages 501-511.
Crossref
Crossref
Ikechi G. Okpechi, Vivekanand Jha, Yeoungjee Cho, Feng Ye, Chukwuonye I. Ijezie, Kailash Jindal, Scott Klarenbach, Muhammad A. Makusidi, Ugochi S. Okpechi‐Samuel, Chimezie Okwuonu, Nikhil Shah, Stephanie Thompson, Marcello Tonelli, David W. Johnson & Aminu K. Bello. (2022)
The case for increased peritoneal dialysis utilization in low‐ and
lower‐middle‐income
countries
. Nephrology 27:5, pages 391-403.
Crossref
Crossref
Angling Yunanto, Agus Rizal Ardy Hariandy Hamid, Nur Rasyid, Maruhum Bonar H. Marbun, Arry Rodjani & Endang Susalit. (2022) The Improvement of Patient's Quality of Life After Kidney Transplantation in Cipto Mangunkusumo Hospital, Indonesia. Transplantation Proceedings 54:3, pages 632-637.
Crossref
Crossref
Amina Chrifi Alaoui, Wiam Touti, Yassine Al Borgi, Tarik Sqalli Houssaini & Karima El Rhazi. (2021) Comparison of quality of life in end‐stage renal disease patients undergoing hemodialysis and peritoneal dialysis in a Moroccan city. Seminars in Dialysis 35:1, pages 50-57.
Crossref
Crossref
Saeed Sheikhgholami, Farbod Ebadifardazar, Aziz Rezapoor, Masih Tajdini & Mojtaba Salarifar. (2021) Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome. Value in Health Regional Issues 24, pages 123-129.
Crossref
Crossref
Michael Willis, Andreas Nilsson, Klas Kellerborg, Philip Ball, Rupert Roe, Shana Traina, Rebecca Beale & Isabelle Newell. (2020) Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model. Diabetes Therapy 12:1, pages 313-328.
Crossref
Crossref
Jacie T. Cooper, Andrew Lloyd, Juan Jose Garcia Sanchez, Elisabeth Sörstadius, Andrew Briggs & Phil McFarlane. (2020) Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Anan Chuasuwan, Siriporn Pooripussarakul, Ammarin Thakkinstian, Atiporn Ingsathit & Oraluck Pattanaprateep. (2020) Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Fei Yang, Meixia Liao, Pusheng Wang, Zheng Yang & Yongguang Liu. (2020) The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations. Applied Health Economics and Health Policy.
Crossref
Crossref
Min‐Woo Jo, Hyeon‐Jeong Lee, Dong‐Ryeol Ryu, Jongha Park, Minsu Ock & Seon‐Ha Kim. (2020) Estimation of population‐based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation. Nephrology 25:7, pages 544-550.
Crossref
Crossref
Tanita Thaweethamcharoen, Prapaporn Noparatayaporn, Suchai Sritippayawan & Nipa Aiyasanon. (2020) Kidney Disease–Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients and Their Caregivers. Value in Health Regional Issues 21, pages 194-200.
Crossref
Crossref
Nader Shaikh, Vinod Rajakumar, Caitlin G. Peterson, Jillian Gorski, Anastasia Ivanova, Lisa Gravens Muller, Yosuke Miyashita, Kenneth J. Smith, Tej Mattoo, Hans G. Pohl, Ranjiv Mathews, Saul P. Greenfield, Steven G. Docimo & Alejandro Hoberman. (2020) Cost-Utility of Antimicrobial Prophylaxis for Treatment of Children With Vesicoureteral Reflux. Frontiers in Pediatrics 7.
Crossref
Crossref
Ming Pei, Rute Aguiar, Agneta A. Pagels, Olof Heimbürger, Peter Stenvinkel, Peter Bárány, Charlotte Medin, Stefan H. Jacobson, Britta Hylander, Bengt Lindholm & Abdul Rashid Qureshi. (2019) Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study. BMC Nephrology 20:1.
Crossref
Crossref
Marc Evans, Eirini Palaka, Hans Furuland, Hayley Bennett, Cecilia Linde, Lei Qin, Phil McEwan & Ameet Bakhai. (2019) The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease. BMC Nephrology 20:1.
Crossref
Crossref
Tanita Thaweethamcharoen, Prapaporn Noparatayaporn, Suchai Sritippayawan & Nipa Aiyasanon. (2019) Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis. Value in Health Regional Issues 18, pages 59-64.
Crossref
Crossref
Pramod Nagaraja & Farid Ghalli. 2019. Blandy's Urology. Blandy's Urology
117
126
.
Derrick Y. Tam, Avery Hughes, Stephen E. Fremes, Saerom Youn, Rebecca L. Hancock-Howard, Peter C. Coyte & Harindra C. Wijeysundera. (2018) A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk. The Journal of Thoracic and Cardiovascular Surgery 155:5, pages 1978-1988.e1.
Crossref
Crossref
Sarah Derrett, Ari Samaranayaka, John B.W. Schollum, Bronwen McNoe, Mark R. Marshall, Sheila Williams, Emma H. Wyeth & Robert J. Walker. (2017) Predictors of Health Deterioration Among Older Adults After 12 Months of Dialysis Therapy: A Longitudinal Cohort Study From New Zealand. American Journal of Kidney Diseases 70:6, pages 798-806.
Crossref
Crossref
Karina V. Grooteman, Mijntje Matheeuwsen, Erwin J. M. van Geenen & Joost P. H. Drenth. (2017) Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort. PLOS ONE 12:5, pages e0177522.
Crossref
Crossref
Howard M. Gebel & Malek Kamoun. (2017) The new KAS: It takes a village. Human Immunology 78:1, pages 1-3.
Crossref
Crossref
Tracey Jones-Hughes, Tristan Snowsill, Marcela Haasova, Helen Coelho, Louise Crathorne, Chris Cooper, Ruben Mujica-Mota, Jaime Peters, Jo Varley-Campbell, Nicola Huxley, Jason Moore, Matt Allwood, Jenny Lowe, Chris Hyde, Martin Hoyle, Mary Bond & Rob Anderson. (2016) Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. Health Technology Assessment 20:62, pages 1-594.
Crossref
Crossref
Marcela Haasova, Tristan Snowsill, Tracey Jones-Hughes, Louise Crathorne, Chris Cooper, Jo Varley-Campbell, Ruben Mujica-Mota, Helen Coelho, Nicola Huxley, Jenny Lowe, Jan Dudley, Stephen Marks, Chris Hyde, Mary Bond & Rob Anderson. (2016) Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. Health Technology Assessment 20:61, pages 1-324.
Crossref
Crossref
L.T. Burgers, A.C. Vahl, J.L. Severens, A.M. Wiersema, P.W.M. Cuypers, H.J.M. Verhagen & W.K. Redekop. (2016) Cost-effectiveness of Elective Endovascular Aneurysm Repair Versus Open Surgical Repair of Abdominal Aortic Aneurysms. European Journal of Vascular and Endovascular Surgery 52:1, pages 29-40.
Crossref
Crossref
Marcelo Soto, Laura Sampietro-Colom, Joan Sagarra & Josep Brugada-Terradellas. (2016) InnovaSEC en acci?n: coste-efectividad de Barostim para el tratamiento de la hipertensi?n arterial refractaria en Espa?a. Revista Espa?ola de Cardiolog?a 69:6, pages 563-571.
Crossref
Crossref
Marcelo Soto, Laura Sampietro-Colom, Joan Sagarra & Josep Brugada-Terradellas. (2016) InnovaSEC in Action: Cost-effectiveness of Barostim in the Treatment of Refractory Hypertension in Spain. Revista Espa?ola de Cardiolog?a (English Edition) 69:6, pages 563-571.
Crossref
Crossref
Eric Y. F. Wan, Julie Y. Chen, Edmond P. H. Choi, Carlos K. H. Wong, Anca K. C. Chan, Karina H. Y. Chan & Cindy L. K. Lam. (2015) Patterns of health-related quality of life and associated factors in Chinese patients undergoing haemodialysis. Health and Quality of Life Outcomes 13:1.
Crossref
Crossref
Fan Yang, Titus Lau, Evan Lee, A. Vathsala, Kee Seng Chia & Nan Luo. (2014) Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). The European Journal of Health Economics 16:9, pages 1019-1026.
Crossref
Crossref
Guillermo A. Herrera. (2015) Evaluating Donor Kidneys for Transplantation. Pathology Case Reviews 20:6, pages 275-280.
Crossref
Crossref
Nanna von der Lippe, Bård Waldum, Fredrik B Brekke, Amin AG Amro, Anna Varberg Reisæter & Ingrid Os. (2014) From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life. BMC Nephrology 15:1.
Crossref
Crossref
Rachel A. Elliott, Koen D. Putman, Matthew Franklin, Lieven Annemans, Nick Verhaeghe, Martin Eden, Jasdeep Hayre, Sarah Rodgers, Aziz Sheikh & Anthony J. Avery. (2014) Cost Effectiveness of a Pharmacist-Led Information Technology Intervention for Reducing Rates of Clinically Important Errors in Medicines Management in General Practices (PINCER). PharmacoEconomics 32:6, pages 573-590.
Crossref
Crossref
Mark Haas. (2014) Donor kidney biopsies: pathology matters, and so does the pathologist. Kidney International 85:5, pages 1016-1019.
Crossref
Crossref
Oleg Borisenko, Joachim Beige, Eric G. Lovett, Uta C. Hoppe & Staffan Bjessmo. (2014) Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings. Journal of Hypertension 32:3, pages 681-692.
Crossref
Crossref
J. M. Yabu, M. W. Anderson, D. Kim, B. D. Bradbury, C. D. Lou, J. Petersen, J. Rossert, G. M. Chertow & D. B. Tyan. (2013) Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrology Dialysis Transplantation 28:11, pages 2908-2918.
Crossref
Crossref
Tanjala S. Purnell, Priscilla Auguste, Deidra C. Crews, Julio Lamprea-Montealegre, Temitope Olufade, Raquel Greer, Patti Ephraim, Johanna Sheu, Daniel Kostecki, Neil R. Powe, Hamid Rabb, Bernard Jaar & L. Ebony Boulware. (2013) Comparison of Life Participation Activities Among Adults Treated by Hemodialysis, Peritoneal Dialysis, and Kidney Transplantation: A Systematic Review. American Journal of Kidney Diseases 62:5, pages 953-973.
Crossref
Crossref
Timothy A Fairbairn, David M Meads, Claire Hulme, Adam N Mather, Sven Plein, Daniel J Blackman & John P Greenwood. (2013) The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 99:13, pages 914-920.
Crossref
Crossref
Davy Beauger, Stéphanie Gentile, Elisabeth Jouve, Bertrand Dussol, Christian Jacquelinet & Serge Briançon. (2013) Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipients. Health and Quality of Life Outcomes 11:1, pages 148.
Crossref
Crossref
Konstadina Griva, Andrew Davenport, Michael Harrison & Stanton P. Newman. (2012) The impact of treatment transitions between dialysis and transplantation on illness cognitions and quality of life – A prospective study. British Journal of Health Psychology 17:4, pages 812-827.
Crossref
Crossref
Sally E. Jensen, Zeeshan Butt, Alex Bill, Talia Baker, Michael M. Abecassis, Allen W. Heinemann, David Cella & Gregory A. Dumanian. (2012) Quality of Life Considerations in Upper Limb Transplantation: Review and Future Directions. The Journal of Hand Surgery 37:10, pages 2126-2135.
Crossref
Crossref
Tone Brit Hortemo Østhus, Valjbona Preljevic, Leiv Sandvik, Toril Dammen & Ingrid Os. (2012) RENAL TRANSPLANT ACCEPTANCE STATUS, HEALTH-RELATED QUALITY OF LIFE AND DEPRESSION IN DIALYSIS PATIENTS. Journal of Renal Care 38:2, pages 98-106.
Crossref
Crossref
Anneke Kramer, Vianda S. Stel, Ronald B. Geskus, E. Jane Tizard, Enrico Verrina, Franz Schaefer, James G. Heaf, Reinhard Kramar, Leah Krischock, Torbj?rn Leivestad, Run?lfur P?lsson, Pietro Ravani & Kitty J. Jager. (2012) The effect of timing of the first kidney transplantation on survival in children initiating renal replacement therapy. Nephrology Dialysis Transplantation 27:3, pages 1256-1264.
Crossref
Crossref
GERMAINE WONG, KIRSTEN HOWARD, JEREMY CHAPMAN, CAROL POLLOCK, STEVEN CHADBAN, GLENN SALKELD, ALLISON TONG, NARELLE WILLIAMS, ANGELA WEBSTER & JONATHAN C CRAIG. (2012) How do people with chronic kidney disease value cancer-related quality of life?. Nephrology 17:1, pages 32-41.
Crossref
Crossref
Wladyslaw GrzeszczakLeszek CzupryniakKatarzyna KolasaCezary SciborskiIsabelle Duprat LomonPhil McEwan. (2012) The Cost-Effectiveness of Saxagliptin Versus NPH Insulin When Used in Combination with Other Oral Antidiabetes Agents in the Treatment of Type 2 Diabetes Mellitus in Poland. Diabetes Technology & Therapeutics 14:1, pages 65-73.
Crossref
Crossref
Edward Appiah Boateng & Linda East. (2011) THE IMPACT OF DIALYSIS MODALITY ON QUALITY OF LIFE: A SYSTEMATIC REVIEW. Journal of Renal Care 37:4, pages 190-200.
Crossref
Crossref
M. Tonelli, N. Wiebe, G. Knoll, A. Bello, S. Browne, D. Jadhav, S. Klarenbach & J. Gill. (2011) Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes. American Journal of Transplantation 11:10, pages 2093-2109.
Crossref
Crossref
K. Saeb-Parsy & C.J.E. Watson. (2011) Kidney transplantation: surgical aspects. Medicine 39:8, pages 443-447.
Crossref
Crossref
Robert A. Montgomery, Bonnie E. Lonze, Karen E. King, Edward S. Kraus, Lauren M. Kucirka, Jayme E. Locke, Daniel S. Warren, Christopher E. Simpkins, Nabil N. Dagher, Andrew L. Singer, Andrea A. Zachary & Dorry L. Segev. (2011) Desensitization in HLA-Incompatible Kidney Recipients and Survival. New England Journal of Medicine 365:4, pages 318-326.
Crossref
Crossref
Michael J. Diamant, Ann Young, Kerri Gallo, Wang Xi, Rita S. Suri, Amit X. Garg & Louise M. Moist. (2011) Hemodialysis in a Satellite Unit. Clinical Journal of the American Society of Nephrology 6:7, pages 1692-1699.
Crossref
Crossref
Rosa Deulofeu, Ma José Blanca, Jorge Twose & Rafael Matesanz. (2011) Actitud y conocimiento de los médicos de atención primaria, emergencias y urgencias en España sobre la donación y el trasplante de órganos y tejidos. Medicina Clínica 136:12, pages 541-548.
Crossref
Crossref
Aaron S. Yarlas, Michelle K. White, Min Yang, Renee N. Saris-Baglama, Peter Galthen Bech & Torsten Christensen. (2010) Measuring the health status burden in hemodialysis patients using the SF-36® health survey. Quality of Life Research 20:3, pages 383-389.
Crossref
Crossref
Cheryl Glover, Pauline Banks, Amanda Carson, Colin R. Martin & Tim Duffy. (2011) Understanding and Assessing the Impact of End-Stage Renal Disease on Quality of Life. The Patient: Patient-Centered Outcomes Research 4:1, pages 19-30.
Crossref
Crossref
Kirsten Howard, Sarah White, Glenn Salkeld, Stephen McDonald, Jonathan C. Craig, Steven Chadban & Alan Cass. (2010) Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis. Value in Health 13:2, pages 196-208.
Crossref
Crossref
Michael J. Diamant, Lori Harwood, Sujana Movva, Barbara Wilson, Larry Stitt, Robert M. Lindsay & Louise M. Moist. (2010) A Comparison of Quality of Life and Travel-Related Factors between In-center and Satellite-Based Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 5:2, pages 268-274.
Crossref
Crossref
Salim K. Mujais, Ken Story, John Brouillette, Tomoko Takano, Steven Soroka, Catherine Franek, David Mendelssohn & Frederic O. Finkelstein. (2009) Health-related Quality of Life in CKD Patients. Clinical Journal of the American Society of Nephrology 4:8, pages 1293-1301.
Crossref
Crossref
Daniel Cukor, Jeremy Coplan, Clinton Brown, Rolf A. Peterson & Paul L. Kimmel. (2008) Course of Depression and Anxiety Diagnosis in Patients Treated with Hemodialysis: A 16-month Follow-up. Clinical Journal of the American Society of Nephrology 3:6, pages 1752-1758.
Crossref
Crossref
W. Aasebo, N. A. Homb-Vesteraas, A. Hartmann & K. Stavem. (2008) Life situation and quality of life in young adult kidney transplant recipients. Nephrology Dialysis Transplantation 24:1, pages 304-308.
Crossref
Crossref
Ylian S. Liem, Johanna L. Bosch & M.G. Myriam Hunink. (2008) Preference-Based Quality of Life of Patients on Renal Replacement Therapy: A Systematic Review and Meta-Analysis. Value in Health 11:4, pages 733-741.
Crossref
Crossref
Daniel Cukor, Jeremy Coplan, Clinton Brown, Steven Friedman, Howard Newville, Michal Safier, Lisa A. Spielman, Rolf A. Peterson & Paul L. Kimmel. (2008) Anxiety Disorders in Adults Treated by Hemodialysis: A Single-Center Study. American Journal of Kidney Diseases 52:1, pages 128-136.
Crossref
Crossref
Zeeshan Butt, Susan E. Yount, Juan Carlos Caicedo, Michael M Abecassis & David Cella. (2007) Quality of life assessment in renal transplant: review and future directions. Clinical Transplantation 22:3, pages 292-303.
Crossref
Crossref
Roberto Marc?n & Jos? Luis Teruel. (2008) Patient outcomes after kidney allograft loss. Transplantation Reviews 22:1, pages 62-72.
Crossref
Crossref
M. Di Paolo & B. Guidi. (2018) Medicolegal Reflections about a Case of Cardiac Death after Renal Transplantation. The International Journal of Artificial Organs 30:7, pages 649-655.
Crossref
Crossref
Daniel Cukor, Jeremy Coplan, Clinton Brown, Steven Friedman, Allyson Cromwell-Smith, Rolf A. Peterson & Paul L. Kimmel. (2007) Depression and Anxiety in Urban Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 2:3, pages 484-490.
Crossref
Crossref
F. Keller, U. Winkler, J. Mayer & S. Stracke. (2007) Should Commercial Organ Donation Be Legalized in Germany? An Ethical Discourse. Transplantation Proceedings 39:2, pages 475-477.
Crossref
Crossref
C. Ll. Morgan, P. McEwan, M. Morrissey, J. R. Peters, C. Poole & C. J. Currie. (2006) Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabetic Medicine 23:10, pages 1100-1105.
Crossref
Crossref
C. J. Currie, C. D. Poole, A. Woehl, C. Ll. Morgan, S. Cawley, M. D. Rousculp, M. T. Covington & J. R. Peters. (2006) The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 49:10, pages 2272-2280.
Crossref
Crossref
CRAIG J. CURRIE, PHIL MCEWAN, CHRIS D. POOLE, ISAAC A.O. ODEYEMI, SHIBENDRA N. DATTA & CHRISTOPHER L. MORGAN. (2006) The impact of the overactive bladder on health-related utility and quality of life. BJU International 97:6, pages 1267-1272.
Crossref
Crossref